Edition:
United Kingdom

Aerpio Pharmaceuticals Inc (ARPO.OQ)

ARPO.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
23 May 2019
Change (% chg)

$0.09 (+8.82%)
Prev Close
$1.02
Open
$1.03
Day's High
$1.11
Day's Low
$1.02
Volume
65,081
Avg. Vol
108,069
52-wk High
$4.35
52-wk Low
$0.88

About

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing treatments for ocular disease. Its lead product candidate is AKB-9778. Its other two pipeline programs include AKB-4924 and ARP-1536. AKB-9778 is a small molecule activator of the Tie-2 pathway, which is being developed for the... (more)

Overall

No Ratios Available.

Financials

  ARPO.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -- -- --
ROI: -- 8.91 13.82
ROE: -- 10.05 15.24

Earnings vs. Estimates